• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

依赖切变的血小板聚集大小。

Shear-dependent platelet aggregation size.

机构信息

School of Engineering and Built Environment, Griffith University, Gold Coast, QLD, Australia.

Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia.

出版信息

Artif Organs. 2020 Dec;44(12):1286-1295. doi: 10.1111/aor.13783. Epub 2020 Aug 15.

DOI:10.1111/aor.13783
PMID:32735693
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7818454/
Abstract

Nonsurgical bleeding is the most frequent complication of left ventricular assist device (LVAD) support. Supraphysiologic shear rates generated in LVAD causes impaired platelet aggregation, which increases the risk of bleeding. The effect of shear rate on the formation size of platelet aggregates has never been reported experimentally, although platelet aggregation size can be considered to be directly relevant to bleeding complications. Therefore, this study investigated the impact of shear rate and exposure time on the formation size of platelet aggregates, which is vital in predicting bleeding in patients with an LVAD. Human platelet-poor plasma (containing von Willebrand factor, vWF) and fluorochrome-labeled platelets were subjected to a range of shear rates (0-10 000 s ) for 0, 5, 10, and 15 minutes using a custom-built blood-shearing device. Formed sizes of platelet aggregates under a range of shear-controlled environment were visualized and measured using microscopy. The loss of high molecular weight (HMW) vWF multimers was quantified using gel electrophoresis and immunoblotting. An inhibition study was also performed to investigate the reduction in platelet aggregation size and HMW vWF multimers caused by either mechanical shear or enzymatic (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13-ADAMTS13, the von Willebrand factor protease) mechanism under low and high shear conditions (360 and 10 000 s ). We found that the average size of platelet aggregates formed under physiological shear rates of 360-3000 s (200-300 μm ) was significantly larger compared to those sheared at >6000 s (50-100 μm ). Furthermore, HMW vWF multimers were reduced with increased shear rates. The inhibition study revealed that the reduction in platelet aggregation size and HWM vWF multimers were mainly associated with ADAMTS13. In conclusion, the threshold of shear rate must not exceed >6000 s in order to maintain the optimal size of platelet aggregates to "plug off" the injury site and stop bleeding.

摘要

非外科性出血是左心室辅助装置 (LVAD) 支持的最常见并发症。LVAD 产生的超生理剪切率会导致血小板聚集受损,从而增加出血风险。尽管血小板聚集大小可以被认为与出血并发症直接相关,但剪切率对血小板聚集形成大小的影响从未在实验中报道过。因此,这项研究调查了剪切率和暴露时间对血小板聚集形成大小的影响,这对于预测 LVAD 患者的出血至关重要。使用定制的血液剪切设备,将富含血小板的人血浆(含有血管性血友病因子,vWF)和荧光标记的血小板暴露于 0-10000s 的一系列剪切率下 0、5、10 和 15 分钟。在一系列剪切控制环境下,使用显微镜可视化和测量血小板聚集的形成大小。使用凝胶电泳和免疫印迹定量测定高分子量(HMW)vWF 多聚体的丢失。还进行了抑制研究,以研究在低剪切和高剪切条件(360 和 10000s)下,由于机械剪切或酶(具有血小板反应蛋白 1 型基序的解整合素和金属蛋白酶 13,血管性血友病因子蛋白酶)机制,血小板聚集大小和 HMW vWF 多聚体的减少。我们发现,在生理剪切率为 360-3000s(200-300μm)下形成的血小板聚集的平均大小明显大于在 >6000s 剪切下形成的血小板聚集(50-100μm)。此外,随着剪切率的增加,HMW vWF 多聚体减少。抑制研究表明,血小板聚集大小和 HWM vWF 多聚体的减少主要与 ADAMTS13 有关。总之,为了保持血小板聚集的最佳大小以“堵塞”损伤部位并停止出血,剪切率的阈值不得超过>6000s。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8919/7818454/a5b64e8094be/AOR-44-1286-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8919/7818454/bedb34c23f91/AOR-44-1286-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8919/7818454/8115bfc4d2b0/AOR-44-1286-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8919/7818454/d006efd38d02/AOR-44-1286-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8919/7818454/93e107e65432/AOR-44-1286-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8919/7818454/a5b64e8094be/AOR-44-1286-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8919/7818454/bedb34c23f91/AOR-44-1286-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8919/7818454/8115bfc4d2b0/AOR-44-1286-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8919/7818454/d006efd38d02/AOR-44-1286-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8919/7818454/93e107e65432/AOR-44-1286-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8919/7818454/a5b64e8094be/AOR-44-1286-g005.jpg

相似文献

1
Shear-dependent platelet aggregation size.依赖切变的血小板聚集大小。
Artif Organs. 2020 Dec;44(12):1286-1295. doi: 10.1111/aor.13783. Epub 2020 Aug 15.
2
The effect of shear stress on the size, structure, and function of human von Willebrand factor.剪切应力对人血管性血友病因子大小、结构及功能的影响。
Artif Organs. 2014 Sep;38(9):741-50. doi: 10.1111/aor.12382.
3
Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular Assist Device-Associated Bleeding.强力霉素抑制 ADAMTS-13 可减少超高生理切应力下 von Willebrand 因子的降解:左心室辅助装置相关出血的治疗意义。
JACC Heart Fail. 2015 Nov;3(11):860-9. doi: 10.1016/j.jchf.2015.06.016. Epub 2015 Oct 7.
4
Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: mechanical demolition and enzymatic cleavage.左心室辅助装置导致病理性血管性血友病因子降解是通过两种不同的机制发生的:机械破坏和酶切。
J Thorac Cardiovasc Surg. 2015 Jan;149(1):281-9. doi: 10.1016/j.jtcvs.2014.09.031. Epub 2014 Sep 18.
5
Acquired von Willebrand factor deficiency caused by LVAD is ADAMTS-13 and platelet dependent.左心室辅助装置(LVAD)导致的获得性血管性血友病因子缺乏是依赖于ADAMTS-13和血小板的。
Thromb Res. 2016 Jan;137:196-201. doi: 10.1016/j.thromres.2015.11.002. Epub 2015 Nov 10.
6
von Willebrand factor disruption and continuous-flow circulatory devices.血管性血友病因子的破坏与连续流循环装置。
J Heart Lung Transplant. 2017 Nov;36(11):1155-1163. doi: 10.1016/j.healun.2017.06.004. Epub 2017 Jun 12.
7
High shear dependent von Willebrand factor self-assembly fostered by platelet interaction and controlled by ADAMTS13.高剪切力依赖的血管性血友病因子自组装由血小板相互作用促进并受ADAMTS13调控。
Thromb Res. 2014 Jun;133(6):1079-87. doi: 10.1016/j.thromres.2014.03.024. Epub 2014 Mar 10.
8
Size regulation of von Willebrand factor-mediated platelet thrombi by ADAMTS13 in flowing blood.在流动血液中,ADAMTS13对血管性血友病因子介导的血小板血栓的大小调节作用
Blood. 2006 Mar 1;107(5):1943-50. doi: 10.1182/blood-2005-07-2972. Epub 2005 Nov 17.
9
Decreased RPM reduces von Willebrand factor degradation with the EVAHEART LVAS: implications for device-specific LVAD management.降低转速可减少EVAHEART左心室辅助系统中血管性血友病因子的降解:对特定设备的左心室辅助装置管理的启示
J Card Surg. 2020 Jul;35(7):1477-1483. doi: 10.1111/jocs.14620.
10
ADAMTS13 inhibition to treat acquired von Willebrand syndrome during mechanical circulatory support device implantation.在机械循环支持装置植入期间用 ADAMTS13 抑制物治疗获得性血管性血友病综合征。
J Thromb Haemost. 2022 Dec;20(12):2797-2809. doi: 10.1111/jth.15889. Epub 2022 Oct 17.

引用本文的文献

1
Anticoagulation during Extracorporeal Membrane Oxygenation (ECMO): A Selective Inhibitor of Activated Factor XII Compared to Heparin in an Model.体外膜肺氧合(ECMO)期间的抗凝:在一个模型中,与肝素相比,活化因子XII的选择性抑制剂。
ACS Pharmacol Transl Sci. 2025 Apr 11;8(5):1260-1269. doi: 10.1021/acsptsci.4c00352. eCollection 2025 May 9.
2
Effect of pulsatility on shear-induced extensional behavior of Von Willebrand factor.搏动对 von Willebrand 因子剪切诱导拉伸行为的影响。
Artif Organs. 2022 May;46(5):887-898. doi: 10.1111/aor.14133. Epub 2021 Dec 13.
3
Application of a Simple Microfluidic Chip Analysis Technology to Evaluate the Inhibitory Role of Protocatechuic Acid on Shear-Induced Platelet Aggregation.

本文引用的文献

1
Low-flow assessment of current ECMO/ECCOR rotary blood pumps and the potential effect on hemocompatibility.当前 ECMO/ECCOR 旋转血泵的低流量评估及其对血液相容性的潜在影响。
Crit Care. 2019 Nov 6;23(1):348. doi: 10.1186/s13054-019-2622-3.
2
Shear-Dependent Platelet Aggregation: Mechanisms and Therapeutic Opportunities.剪切力依赖性血小板聚集:机制与治疗机遇
Front Cardiovasc Med. 2019 Sep 20;6:141. doi: 10.3389/fcvm.2019.00141. eCollection 2019.
3
Evaluation of anticoagulation and nonsurgical major bleeding in recipients of continuous-flow left ventricular assist devices.
应用简单微流控芯片分析技术评估原儿茶酸对剪切诱导的血小板聚集的抑制作用。
Evid Based Complement Alternat Med. 2021 May 18;2021:5574413. doi: 10.1155/2021/5574413. eCollection 2021.
连续流左心室辅助装置接受者的抗凝与非手术性大出血评估
Artif Organs. 2019 Aug;43(8):736-744. doi: 10.1111/aor.13456. Epub 2019 Apr 24.
4
Shear-stress mediated nitric oxide production within red blood cells: A dose-response.红细胞内剪切应力介导的一氧化氮生成:剂量反应关系
Clin Hemorheol Microcirc. 2019;71(2):203-214. doi: 10.3233/CH-189412.
5
Stress and Exposure Time on von Willebrand Factor Degradation.压力和暴露时间对血管性血友病因子降解的影响
Artif Organs. 2019 Feb;43(2):199-206. doi: 10.1111/aor.13323. Epub 2018 Oct 29.
6
Visualization of erythrocyte deformation induced by supraphysiological shear stress.超生理剪切应力诱导的红细胞变形的可视化。
Int J Artif Organs. 2018 Dec;41(12):838-844. doi: 10.1177/0391398818793387. Epub 2018 Aug 21.
7
In Vitro Hemocompatibility Evaluation of Ventricular Assist Devices in Pediatric Flow Conditions: A Benchmark Study.小儿血流条件下心室辅助装置的体外血液相容性评估:一项基准研究。
Artif Organs. 2018 Nov;42(11):1028-1034. doi: 10.1111/aor.13165. Epub 2018 Aug 12.
8
Arterial Pulsatility and Circulating von Willebrand Factor in Patients on Mechanical Circulatory Support.机械循环支持患者的动脉脉动性和循环血管性血友病因子。
J Am Coll Cardiol. 2018 May 15;71(19):2106-2118. doi: 10.1016/j.jacc.2018.02.075.
9
Acquired von Willebrand syndrome and impaired platelet function during venovenous extracorporeal membrane oxygenation: Rapid onset and fast recovery.获得性血管性血友病综合征和体外膜肺氧合期间血小板功能受损:快速发作和快速恢复。
J Heart Lung Transplant. 2018 Aug;37(8):985-991. doi: 10.1016/j.healun.2018.03.013. Epub 2018 Mar 17.
10
Platelet Secretion Defects and Acquired von Willebrand Syndrome in Patients With Ventricular Assist Devices.心室辅助装置患者的血小板分泌缺陷和获得性血管性血友病。
J Am Heart Assoc. 2018 Jan 13;7(2):e006519. doi: 10.1161/JAHA.117.006519.